![Frédérique Welgryn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frédérique Welgryn
Corporate Officer/Principal bei HRA Pharma Development SARL
Profil
Frédérique Welgryn is currently the Chief Strategic Operations & Innovation Officer at HRA Pharma Development SARL.
Previously, she worked as a Director at YSOPIA Biosciences SA, a Manager-Sales & Marketing at Sanofi, and a Manager-Sales & Marketing at AstraZeneca SAS.
Aktive Positionen von Frédérique Welgryn
Unternehmen | Position | Beginn |
---|---|---|
HRA Pharma Development SARL
![]() HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Corporate Officer/Principal | 01.11.2012 |
Ehemalige bekannte Positionen von Frédérique Welgryn
Unternehmen | Position | Ende |
---|---|---|
AstraZeneca SAS
![]() AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Vertrieb & Marketing | - |
SANOFI | Vertrieb & Marketing | - |
YSOPIA Biosciences SA
![]() YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SANOFI | Health Technology |
Private Unternehmen | 3 |
---|---|
AstraZeneca SAS
![]() AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Health Technology |
HRA Pharma Development SARL
![]() HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Health Technology |
YSOPIA Biosciences SA
![]() YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Health Technology |